Long-term effectiveness of ultra-low doses of rituximab in rheumatoid arthritis

Category Primary study
ConferenceArthritis and Rheumatology
Year 2021
This article has no abstract
Epistemonikos ID: c759fb06a6cc826fd083c643be711901c3c5e009
First added on: Apr 30, 2026